Character Biosciences
Character Biosciences is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.
About Character Biosciences
Character Biosciences is a therapeutics company that uses genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to identify the molecular drivers of disease progression and develop innovative targeted medicines. Its dedication to patients is reflected in the high standards set to ensure privacy, data security, ethics, scientific rigor, and a meaningful impact on patient health. To enable clinical genomic research, the company collaborates with patients, providers, payers, and scientists to create deeply phenotyped patient cohorts.
Company Facts
- Headquarters
- Jersey City
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $137,000,000
- Last Funding Type
- series_b
- Last Funding Date
- 2025-09-17
- Website
- characterbio.com
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Clinical Trials, Health Care, Health Diagnostics, Therapeutics
Canonical: https://fsome.com/organization/character-biosciences-26022 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.